These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16981833)

  • 1. Novel targets in pancreatic cancer: focus on future paths to therapy.
    Cohen SJ; Burtness BA
    Expert Opin Ther Targets; 2006 Oct; 10(5):771-5. PubMed ID: 16981833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for the treatment of pancreatic cancer.
    Van Laethem JL; Marechal R
    Expert Opin Emerg Drugs; 2007 May; 12(2):301-11. PubMed ID: 17604503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates in pancreatic cancer: Modest gains and hopeful targets.
    Draper A
    J Oncol Pharm Pract; 2019 Jan; 25(1):101-109. PubMed ID: 29580162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies.
    Nedaeinia R; Avan A; Manian M; Salehi R; Ghayour-Mobarhan M
    Curr Drug Targets; 2014; 15(14):1293-301. PubMed ID: 25429712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting heat shock response pathways to treat pancreatic cancer.
    Xia Y; Rocchi P; Iovanna JL; Peng L
    Drug Discov Today; 2012 Jan; 17(1-2):35-43. PubMed ID: 21986108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Epidermal Growth Factor Receptor-Related Signaling Pathways in Pancreatic Cancer.
    Philip PA; Lutz MP
    Pancreas; 2015 Oct; 44(7):1046-52. PubMed ID: 26355547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Merika E; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel targets in prostate cancer.
    Berthold DR; Moore MJ
    Expert Opin Ther Targets; 2006 Oct; 10(5):777-80. PubMed ID: 16981834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer: molecular pathogenesis and new therapeutic targets.
    Wong HH; Lemoine NR
    Nat Rev Gastroenterol Hepatol; 2009 Jul; 6(7):412-22. PubMed ID: 19506583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agents targeting prostate cancer bone metastasis.
    Mohammad KS; Fournier PG; Guise TA; Chirgwin JM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1079-88. PubMed ID: 19719455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting signaling pathways in ovarian cancer.
    Reibenwein J; Krainer M
    Expert Opin Ther Targets; 2008 Mar; 12(3):353-65. PubMed ID: 18269344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic Neoplasms and Autophagy.
    Barton LA; Ren J
    Curr Drug Targets; 2018; 19(9):1018-1023. PubMed ID: 27358060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target therapies in pancreatic carcinoma.
    Silvestris N; Gnoni A; Brunetti AE; Vincenti L; Santini D; Tonini G; Merchionne F; Maiello E; Lorusso V; Nardulli P; Azzariti A; Reni M
    Curr Med Chem; 2014; 21(8):948-65. PubMed ID: 23992319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targets of triple-negative breast cancer: a review.
    Jamdade VS; Sethi N; Mundhe NA; Kumar P; Lahkar M; Sinha N
    Br J Pharmacol; 2015 Sep; 172(17):4228-37. PubMed ID: 26040571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-gene signaling pathways in pancreatic cancer.
    Drakaki A; Iliopoulos D
    Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
    Matsuoka T; Yashiro M
    World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics.
    Beeram M; Patnaik A
    Hematol Oncol Clin North Am; 2002 Oct; 16(5):1089-100. PubMed ID: 12512384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel drug targets based on association between inflammation and pancreatic ductal adenocarcinoma.
    Saif MW
    JOP; 2010 Jul; 11(4):403-4; author reply 411. PubMed ID: 20601821
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
    Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
    Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted drug delivery in pancreatic cancer.
    Yu X; Zhang Y; Chen C; Yao Q; Li M
    Biochim Biophys Acta; 2010 Jan; 1805(1):97-104. PubMed ID: 19853645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.